BIODANE PHARMA A/S — Credit Rating and Financial Key Figures
CVR number: 28310102
Staushedevejen 10, 6621 Gesten
tel: 75557411
https://biodanepharma.com/
Income statement (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 1 508.45 | 1 628.85 | 3 701.32 | 2 371.67 | 3 070.74 |
| Costs of management | - 414.81 | - 366.88 | - 311.51 | - 428.40 | -1 103.65 |
| Costs of distribution | - 756.12 | - 643.36 | -1 029.85 | -1 327.04 | -1 088.15 |
| EBIT | 337.53 | 618.60 | 2 359.95 | 616.23 | 878.94 |
| Other financial income | 33.35 | 48.80 | 99.72 | 165.33 | 297.96 |
| Other financial expenses | -25.45 | -26.95 | -26.79 | -29.82 | -22.73 |
| Pre-tax profit | 345.42 | 640.46 | 2 432.88 | 751.74 | 1 154.16 |
| Income taxes | -88.67 | - 140.92 | - 535.23 | - 165.38 | - 253.92 |
| Net earnings | 256.75 | 499.54 | 1 897.65 | 586.35 | 900.25 |
Assets (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Tangible assets total | |||||
| Investments total | |||||
| Long term receivables total | |||||
| Finished products/goods | 202.57 | 206.14 | 219.62 | 340.32 | 319.19 |
| Inventories total | 202.57 | 206.14 | 219.62 | 340.32 | 319.19 |
| Current trade debtors | 292.64 | 170.98 | 611.30 | 607.06 | 729.72 |
| Current amounts owed by group member comp. | 1 078.77 | 1 788.30 | 3 452.50 | 4 340.02 | 2 871.98 |
| Prepayments and accrued income | 5.02 | ||||
| Current other receivables | 7.00 | 43.58 | |||
| Short term receivables total | 1 383.42 | 1 959.28 | 4 063.80 | 4 990.66 | 3 601.70 |
| Cash and bank deposits | 189.15 | 261.21 | 750.00 | 19.59 | 361.79 |
| Cash and cash equivalents | 189.15 | 261.21 | 750.00 | 19.59 | 361.79 |
| Balance sheet total (assets) | 1 775.14 | 2 426.63 | 5 033.42 | 5 350.57 | 4 282.68 |
Equity and liabilities (kDKK)
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 552.00 | 552.00 | 552.00 | 552.00 | 552.00 |
| Shares repurchased | 2 000.00 | 2 871.98 | |||
| Retained earnings | 850.23 | 1 106.98 | 1 606.51 | 1 504.16 | - 781.46 |
| Profit of the financial year | 256.75 | 499.54 | 1 897.65 | 586.35 | 900.25 |
| Shareholders equity total | 1 658.98 | 2 158.51 | 4 056.16 | 4 642.52 | 3 542.76 |
| Non-current liabilities total | |||||
| Current trade creditors | 38.56 | 32.79 | 169.42 | 79.64 | 250.37 |
| Current owed to group member | 446.03 | 146.33 | |||
| Short-term deferred tax liabilities | 33.63 | 140.92 | 535.23 | 165.38 | 253.92 |
| Other non-interest bearing current liabilities | 43.97 | 94.41 | 272.60 | 17.00 | 89.29 |
| Current liabilities total | 116.16 | 268.12 | 977.25 | 708.05 | 739.91 |
| Balance sheet total (liabilities) | 1 775.14 | 2 426.63 | 5 033.42 | 5 350.57 | 4 282.68 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.